Clinical Trial Update: A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus [Phase 3]

View source ↗

Summary

Phase 3 trial comparing brincidofovir to valganciclovir for prevention of cytomegalovirus in transplant patients; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Disease
• Kidney Transplant Infection

Drugs mentioned

• Brincidofovir (brincidofovir)
• Valganciclovir (Valganciclovir)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Cytomegalovirus Disease, Kidney Transplant Infection | Phase 3 | Status: TERMINATED | Results posted: 2021-07-16